BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32296467)

  • 21. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.
    Owens C; Irwin M
    Crit Rev Clin Lab Sci; 2012; 49(3):85-115. PubMed ID: 22646747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline
    Djos A; Treis D; Fransson S; Gordon Murkes L; Wessman S; Ásmundsson J; Markström A; Kogner P; Martinsson T
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research progress of neuroblastoma related gene variations.
    Cao Y; Jin Y; Yu J; Wang J; Yan J; Zhao Q
    Oncotarget; 2017 Mar; 8(11):18444-18455. PubMed ID: 28055978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroblastoma pathogenesis: deregulation of embryonic neural crest development.
    Tomolonis JA; Agarwal S; Shohet JM
    Cell Tissue Res; 2018 May; 372(2):245-262. PubMed ID: 29222693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular biology of neuroblastoma.
    Maris JM; Matthay KK
    J Clin Oncol; 1999 Jul; 17(7):2264-79. PubMed ID: 10561284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pleiotropic effect of common
    Zhao J; Zhu Y; Xie X; Yao Y; Zhang J; Zhang R; Huang L; Cheng J; Xia H; He J; Zhang Y
    Aging (Albany NY); 2019 Feb; 11(4):1252-1261. PubMed ID: 30799307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics and genomics of neuroblastoma.
    Capasso M; Diskin SJ
    Cancer Treat Res; 2010; 155():65-84. PubMed ID: 20517688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zebrafish as a model to study neuroblastoma development.
    Casey MJ; Stewart RA
    Cell Tissue Res; 2018 May; 372(2):223-232. PubMed ID: 29027617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia.
    Vivancos Stalin L; Gualandi M; Schulte JH; Renella R; Shakhova O; Mühlethaler-Mottet A
    Front Oncol; 2019; 9():275. PubMed ID: 31058082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoblastoma and Neuroblastoma Predisposition and Surveillance.
    Kamihara J; Bourdeaut F; Foulkes WD; Molenaar JJ; Mossé YP; Nakagawara A; Parareda A; Scollon SR; Schneider KW; Skalet AH; States LJ; Walsh MF; Diller LR; Brodeur GM
    Clin Cancer Res; 2017 Jul; 23(13):e98-e106. PubMed ID: 28674118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroblastoma: biology, prognosis, and treatment.
    Park JR; Eggert A; Caron H
    Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MIBG in neuroblastoma diagnosis and treatment.
    Olecki E; Grant CN
    Semin Pediatr Surg; 2019 Dec; 28(6):150859. PubMed ID: 31931960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
    Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
    Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular pathogenesis of peripheral neuroblastic tumors.
    Janoueix-Lerosey I; Schleiermacher G; Delattre O
    Oncogene; 2010 Mar; 29(11):1566-79. PubMed ID: 20101209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncologic Phenotype of Peripheral Neuroblastic Tumors Associated With PHOX2B Non-Polyalanine Repeat Expansion Mutations.
    Heide S; Masliah-Planchon J; Isidor B; Guimier A; Bodet D; Coze C; Deville A; Thebault E; Pasquier CJ; Cassagnau E; Pierron G; Clément N; Schleiermacher G; Amiel J; Delattre O; Peuchmaur M; Bourdeaut F
    Pediatr Blood Cancer; 2016 Jan; 63(1):71-7. PubMed ID: 26375764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors.
    Ahmed AA; Zhang L; Reddivalla N; Hetherington M
    Pediatr Hematol Oncol; 2017 Apr; 34(3):165-185. PubMed ID: 28662353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk-based management: current concepts of treating malignant solid tumors of childhood.
    Grosfeld JL
    J Am Coll Surg; 1999 Oct; 189(4):407-25. PubMed ID: 10509467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human neuroblastoma: from basic science to clinical debut of cellular oncogenes.
    Schwab M
    Naturwissenschaften; 1999 Feb; 86(2):71-8. PubMed ID: 10084150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroblastoma: biology and therapy.
    Matthay KK
    Oncology (Williston Park); 1997 Dec; 11(12):1857-66; discussion 1869-72, 1875. PubMed ID: 9436190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of whole chromosome X predicts prognosis of neuroblastoma patients with numerical genomic profile.
    Parodi S; Pistorio A; Erminio G; Ognibene M; Morini M; Garaventa A; Gigliotti AR; Haupt R; Frassoni F; Pezzolo A
    Pediatr Blood Cancer; 2019 May; 66(5):e27635. PubMed ID: 30688024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.